Delayed pain decrease following M1 tDCS in spinal cord injury: A randomized controlled clinical trial
Aurore Thibaut, Sandra Carvalho, Leslie R Morse, Ross Zafonte, Felipe Fregni, Aurore Thibaut, Sandra Carvalho, Leslie R Morse, Ross Zafonte, Felipe Fregni
Abstract
Despite some encouraging findings for the treatment of neuropathic pain in patients with spinal cord injury (SCI), transcranial direct current stimulation (tDCS) directed to the primary motor cortex (M1) has faced some mixed results. Prior to translating this technology to clinical care, consistent results and durable effects need to be found. We, therefore, aimed to assess the direct and long-term effects of tDCS on pain following SCI. We performed a two-phase randomized sham-controlled clinical trial where patients received 5days of tDCS followed by a 3-month follow-up period (Phase I); then, Phase II consisted of 10days of tDCS with an 8-week follow-up period. We assessed the level of pain with the Visual Analogue Scale (VAS). Patients' quality of life and life satisfaction were also evaluated. 33 patients were enrolled in Phase I and 9 in Phase II. We observed a treatment effect at 1-week follow-up for Phase I and at 4-week follow-up for Phase II. The overall level of pain was significantly lower for the active group, as compared to sham, in Phase II. Our exploratory study shows that tDCS does seem to be a promising tool to manage pain in patients with SCI and repeated stimulation sessions are needed to induce long-lasting effects. Based on our protocol, it appears that adding a second treatment period could induce long-lasting effects. Clinicaltrials.gov identification number: NCT01599767.
Keywords: Central sensitization; Neuromodulation; Pain; Spinal cord injury; Transcranial direct current stimulation; Visual analogue scale.
Copyright © 2017 Elsevier B.V. All rights reserved.
Source: PubMed
Aankomende klinische onderzoeken
-
October University for Modern Sciences and ArtsWerving
-
Uskudar UniversityNog niet aan het wervenMusculoskeletale pijn | BeroepsziektenTurkije (Türkiye)
-
Milton S. Hershey Medical CenterAxogen CorporationNog niet aan het wervenParotis kanker | Parotidectomie | Syndroom van Frey | Parotidectomie, door de patiënt gerapporteerde resultaten | Parotiskliertumor
-
University of the Italian SwitzerlandUniversita di VeronaNog niet aan het wervenLast van mantelzorgers | Psychische noodZwitserland
-
Ain Shams UniversityNog niet aan het wervenHip Abductor Insufficiency Following Total Hip Arthroplasty
-
University of CalgaryNog niet aan het wervenHypospadie | Ureteropelvic Junction ObstructieCanada
-
Reinovax Biologics Co., LTDNog niet aan het wervenA Phase Ⅲ Clinical Trial of an Investigative 24-valent Pneumococcal Polysaccharide Conjugate VaccinePneumokokken infectieziekteChina
-
Research IncWervingPostoperative Nasal Fibrosis After RhinoplastyColombia
-
Abramson Cancer Center at Penn MedicineNog niet aan het werven
-
Aligos TherapeuticsNog niet aan het wervenGezonde deelnemersVerenigde Staten
-
PT Equilab InternationalNestle IndonesiaWerving
-
Stanford UniversityNog niet aan het werven